IT1284076B1 - Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro - Google Patents

Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro

Info

Publication number
IT1284076B1
IT1284076B1 IT96MI001309A ITMI961309A IT1284076B1 IT 1284076 B1 IT1284076 B1 IT 1284076B1 IT 96MI001309 A IT96MI001309 A IT 96MI001309A IT MI961309 A ITMI961309 A IT MI961309A IT 1284076 B1 IT1284076 B1 IT 1284076B1
Authority
IT
Italy
Prior art keywords
drugs
fragments
metabolites
active
specific antibody
Prior art date
Application number
IT96MI001309A
Other languages
English (en)
Inventor
Ivo Volpato
Bernard Bizzini
Ernst Bernhard Grabitz
Original Assignee
Dox Al Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dox Al Italia Spa filed Critical Dox Al Italia Spa
Priority to IT96MI001309A priority Critical patent/IT1284076B1/it
Publication of ITMI961309A0 publication Critical patent/ITMI961309A0/it
Priority to AT97930416T priority patent/ATE407149T1/de
Priority to EP97930416A priority patent/EP0934339B1/en
Priority to PCT/EP1997/003358 priority patent/WO1997049732A1/en
Priority to DE69738965T priority patent/DE69738965D1/de
Priority to AU34374/97A priority patent/AU3437497A/en
Publication of ITMI961309A1 publication Critical patent/ITMI961309A1/it
Application granted granted Critical
Publication of IT1284076B1 publication Critical patent/IT1284076B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IT96MI001309A 1996-06-27 1996-06-27 Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro IT1284076B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT96MI001309A IT1284076B1 (it) 1996-06-27 1996-06-27 Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro
AT97930416T ATE407149T1 (de) 1996-06-27 1997-06-26 Detoxifizierung durch intramuskulär verabreichte f(ab')2 fragmente
EP97930416A EP0934339B1 (en) 1996-06-27 1997-06-26 Detoxification by intramuscular administration of F(ab') 2 fragments
PCT/EP1997/003358 WO1997049732A1 (en) 1996-06-27 1997-06-26 IgG IMMUNOGLOBULINS AND F(ab')2 FRAGMENTS THEREOF, SPECIFIC FOR DRUGS AND METABOLITES THEREOF, AND THEIR USE FOR DETOXIFICATION PURPOSES
DE69738965T DE69738965D1 (de) 1996-06-27 1997-06-26 Detoxifizierung durch intramuskulär verabreichte F(ab')2 Fragmente
AU34374/97A AU3437497A (en) 1996-06-27 1997-06-26 Igg immunoglobulins and f(ab')2 fragments thereof, specific for drugs and metabolites thereof, and their use for detoxification purposes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001309A IT1284076B1 (it) 1996-06-27 1996-06-27 Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro

Publications (3)

Publication Number Publication Date
ITMI961309A0 ITMI961309A0 (it) 1996-06-27
ITMI961309A1 ITMI961309A1 (it) 1997-12-27
IT1284076B1 true IT1284076B1 (it) 1998-05-08

Family

ID=11374491

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI001309A IT1284076B1 (it) 1996-06-27 1996-06-27 Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro

Country Status (6)

Country Link
EP (1) EP0934339B1 (it)
AT (1) ATE407149T1 (it)
AU (1) AU3437497A (it)
DE (1) DE69738965D1 (it)
IT (1) IT1284076B1 (it)
WO (1) WO1997049732A1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705376D0 (en) * 1997-03-14 1997-04-30 Harris William J Antibody fragment formulations and assay formats for detecting the presence an d concentration of analytes
GB0003360D0 (en) 2000-02-14 2000-04-05 Novartis Ag Monoclonal antibodies
WO2001081424A1 (en) * 2000-04-20 2001-11-01 The Board Of Trustees Of The University Of Arkansas Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
US6669937B2 (en) * 2000-04-20 2003-12-30 The Board Of Trustees Of The University Of Arkansas Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs
US7632929B2 (en) 2000-04-20 2009-12-15 The Board Of Trustees Of The University Of Arkansas Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
ITMI20010347A1 (it) 2001-02-21 2002-08-21 Grisotech S A Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale
EP1331219A1 (en) * 2002-01-23 2003-07-30 Drug Abuse Sciences, Inc. New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
ES2415655T3 (es) 2006-06-15 2013-07-26 The Board Of Trustees Of The University Of Arkansas Anticuerpos monoclonales que reconocen selectivamente Metanfetamina y compuestos similares a Metanfetamina
EP2140263B1 (en) 2007-04-20 2017-01-04 The Board of Trustees of The University of Arkansas Hapten compounds and compositions and uses thereof
US9023353B2 (en) 2013-03-13 2015-05-05 The Board Of Trustees Of The University Of Arkansas Anti-(+)—methamphetamine monoclonal antibodies
CN111060690B (zh) * 2019-10-08 2023-07-07 浙江工商大学 一种检测喹乙醇的时间分辨荧光免疫分析试剂盒及其应用
CN111154000A (zh) * 2020-01-16 2020-05-15 新乡学院 一种抗西马特罗单克隆抗体及其应用
CN111269319B (zh) * 2020-02-21 2021-10-29 华南农业大学 一种特异性纳米抗体Nb2F7及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol

Also Published As

Publication number Publication date
AU3437497A (en) 1998-01-14
ATE407149T1 (de) 2008-09-15
DE69738965D1 (de) 2008-10-16
ITMI961309A0 (it) 1996-06-27
ITMI961309A1 (it) 1997-12-27
EP0934339A1 (en) 1999-08-11
WO1997049732A1 (en) 1997-12-31
EP0934339B1 (en) 2008-09-03

Similar Documents

Publication Publication Date Title
DE69633717D1 (de) Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis
IT1284076B1 (it) Frammenti f(ab')2 e relative immunoglobuline igg, attivi come anticorpi specifici verso farmaci e i loro metaboliti, e loro
ATE512224T1 (de) Rekonstituierter menschlicher anti-hm.1 antikörper
KR950005327A (ko) 임파구 항원 CD2 및 종양 항원을 인식하는 이특이적 트리거(Trigger) 분자
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
EP0701571A1 (en) ANTIBODY FRAGMENTS IN THERAPY
DE69636748D1 (de) Bispezifischer antikörper zur effektiven behandlung von b-zell lymphomen und zellinien
PT941121E (pt) Preparados farmaceuticos liofilizados, estaveis, de anticorpos monoclonais ou policlonais
RU2000109293A (ru) Моноклональное антитело, полученное с помощью интегринассоциированного белка, его фрагмент Fab, Fab' или F(ab')2, гибридома, продуцирующая моноклональное антитело (вариант), антилейкемическое средство
ATE330631T1 (de) Antikörperfragmente zur lokalen behandlung von augenerkrankungen
EP0755409A4 (en) MONOCLONAL ANTIBODIES AGAINST ONCOFOTAL PROTEIN FOR THE TREATMENT AND DETECTION OF CANCER
CY1109817T1 (el) Ολιγο-βητα-(1,3)-γλυκανη και μονοκλωνικα αντισωματα εναντιον καρκινου
DE60129278D1 (de) Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen
DK0433088T3 (da) Monoklonale antistoffer, der reagerer med et humant atheromaassocieret antigen
NO873495D0 (no) Monoklonale antistoffer og peptider egnet for behandling og diagnose av hiv-infeksjoner.
DE60034564D1 (de) Menschlicher cytokinrezeptor
EA200401081A1 (ru) Fab-фрагменты моноклонального антитела человека, направленные против гликопротеина e2 hcv и обладающие нейтрализующей активностью in vitro
DK0476226T3 (da) Monoklonalt antistof mod humant IgE
BR0210648A (pt) Variante de uma molécula imunointerativa, anticorpo monoclonal, forma disimunizada de anticorpo monoclonal 3b6, método para a geração de um anticorpo monoclonal desimunizado, molécula de anticorpo desimunizada, anticorpo desimunizado, anticorpo monoclonal de murino variante 3b6 desimunizado, variante de um anticorpo monoclonal de murino 3b6 desimunizado para uso em humanos, método para a detecção de um coágulo sanguìneo em um paciente humano, método para a detecção de um coágulo sanguìneo ou de um seu fragmento de ligação a antìgeno, método para a facilitação da dissolução ou da remoção de um coágulo sanguìneo em um humano, uso de um anticorpo monoclonal derivado de murino variante, e, conjugado
MX9301858A (es) Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv.
DE69615843D1 (de) Il-8 antagonisten zur behandlung von asthma
ATE77243T1 (de) E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
JPH11279199A5 (it)

Legal Events

Date Code Title Description
0001 Granted